• About Us
      • Back
      • History
          • Back
          • Company background
          • Path to success
          • Milestones in Biohit’s history
      • Biohit Management
      • Quality
          • Back
          • Responsibility
      • Research and Development
      • Career
      • Glossary
      • News and Events
      • Privacy policy
  • Products
      • Back
      • Diagnostic tests
          • Back
          • GastroPanel ELISA
          • GastroPanel® quick test
          • Biohit Active B12 ELISA
          • Biohit Total 25OH Vitamin D ELISA
          • Biohit Calprotectin ELISA
          • Helicobacter Pylori Quick Test
          • Helicobacter Pylori UFT300 Quick Test
          • ColonView Quick Test
          • Lactose Intolerance Quick Test
          • Celiac Disease Quick Test
      • Monoclonal Antibodies
      • Acetaldehyde Binding Products
          • Back
          • Acetium lozenge
          • Acetium capsule
      • Dysbiosis
          • Back
          • GA-map Dysbiosis Test
      • Product Brochures
  • Scientific
      • Back
      • Key Biohit studies
      • Study protocols
      • Presentations
      • Literature
  • Laboratory
      • Back
      • Determination of Acetaldehyde
      • How to reduce acetaldehyde exposure
  • Investors
      • Back
      • Strategy
          • Back
          • Short term risks and uncertainty factors
          • Outlook for 2021
          • Operating Environment
      • Shareholders
          • Back
          • Number Dispersion
          • Notifications on major holdings
          • Holding Distribution
          • Insider Regulations
          • Insider Register
          • Major Shareholders
      • Financials
          • Back
          • Key Ratios
          • Financial reports
          • Profit share proposal
          • Annual Reports
      • Share Information
          • Back
          • Share Capital
          • Redemption Rights
          • Share Monitor
          • Share History
      • Group Management
          • Back
          • CEO and President
          • Board of Directors
          • Subsidiary management
          • Management
      • Corporate Governance
      • Stock Exchange Releases
          • Back
          • Order Releases
      • Fact sheet for investors
          • Back
          • IR calender
  • Partnering
      • Back
      • Acetium partnering
      • GastroPanel partnering
  • Contact
      • Back
      • Locations
      • Subsidiaries
      • Distributors
    • Finnish

Insider Register

.

Additional Information: Insider Regulations

Biohit Oyj
Laippatie 1, Helsinki, Finland
+358 9 773 861
info(at)biohit.fi
Subsidiary sites
Biohit Healthcare Ltd (UK) | Biohit Healthcare Srl (italy)
To Top
© 2022 Biohit Oyj, All rights reserved.
Contact | Legal Notice | Privacy Policy | Cookies
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT